【摘要】 目的 探讨CT引导下神经内窥镜微创术治疗高血压脑出血（HICH）的效果及预后情况。方法 选取2021年1月至2025年1月本院收治的85例HICH患者，按照治疗方式分为对照组（无创引流术）与试验组（CT引导下神经内窥镜微创术）。比较两组围术期指标、神经功能、并发症及预后。结果 试验组手术、血肿清除及住院时间短于对照组，术中出血量低于对照组，血肿清除率高于对照组（P<0.05）。术后3个月试验组NSE、 NPY低于对照组，BDNF高于对照组（P<0.05）。试验组并发症发生率4.44%，低于对照组的20.00%(P<0.05)。试验组预后良好率93.33%，高于对照组的77.50%(P<0.05)。结论 CT引导下神经内窥镜微创术治疗HICH用时短，可缓解患者的神经损伤，降低并发症发生率，改善其预后转归。更多还原

【Abstract】 Objective To explore the efficacy and prognosis of CT-guided minimally invasive neuroendoscopy in the treatment of hypertensive intracerebral hemorrhage(HICH). Methods 85 patients with HICH admitted to our hospital from January 2021 to January 2025 were selected and divided into control group(non-invasive drainage) and experimental group(CT-guided minimally invasive neuroendoscopy) according to the treatment methods. The perioperative indicators, neurological function, complications and prognosis of the two groups were compared. Results The time of operation, hematoma clearance and hospital stay in the experimental group were shorter than those in the control group, the intraoperative blood loss was lower than that in the control group, and the hematoma clearance rate was higher than that in the control group(P <0.05). Three months after operation, the NSE and NPY in the experimental group were lower than those in the control group, and the BDNF was higher than that in the control group(P <0.05). The incidence of complications in the experimental group was 4.44%, lower than 20.00% in the control group(P <0.05). The good prognosis rate of the experimental group was 93.33%, higher than 77.50% of the control group(P <0.05). Conclusions CT-guided neuroendoscopic minimally invasive surgery for HICH takes a short time, can alleviate nerve injury in patients, reduce the incidence of complications, and improve their prognosis.更多还原